Phoenix Pharmalabs Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Crowdfunding
  • Latest Deal Amount
  • $1.07M
Latest Deal Amount
  • Investors
  • 10

Phoenix Pharmalabs General Information

Description

Developers of drugs designed to treat pain and opiate addiction. The company's drugs offer pathways to potent pain therapy without the risk of addiction and serious side effects, enabling healthcare providers to get their patients cured.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 999 West 1500 South
  • Suite 600
  • Woods Cross, UT 84087
  • United States
+1 (312) 000-0000

Phoenix Pharmalabs Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Phoenix Pharmalabs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Equity Crowdfunding 18-Jun-2021 $1.07M 00.000 000.00 Completed Pre-Clinical Trials
6. Angel (individual) 00.000 000 Completed Pre-Clinical Trials
5. Equity Crowdfunding 08-Apr-2019 00.00 00.000 Completed Pre-Clinical Trials
4. Grant 01-Jan-2018 00.000 00000 Completed Pre-Clinical Trials
3. Grant 01-Jan-2011 00000 00000 Completed Startup
2. Angel (individual) 01-Jan-2011 $270K $270K Completed Startup
1. Grant 01-Jan-2004 $100K Completed Startup
To view Phoenix Pharmalabs’s complete valuation and funding history, request access »

Phoenix Pharmalabs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developers of drugs designed to treat pain and opiate addiction. The company's drugs offer pathways to potent pain thera
Drug Discovery
Woods Cross, UT
6 As of 2021
00.000
00.00 0000-00-00
000000000000 00.000

00000000

ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor i
0000 000000000
Boston, MA
00 As of 0000
00000
00000000

0000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
0000 000000000
Barcelona, Spain
00 As of 0000
0000
000000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phoenix Pharmalabs Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrexion Therapeutics Venture Capital-Backed Boston, MA 00 00000 00000000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 0000 000000000000 0000
You’re viewing 2 of 2 competitors. Get the full list »

Phoenix Pharmalabs Patents

Phoenix Pharmalabs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200276186-A1 Use of morphinans for treating cocaine addiction, pruritis, and seizure disorders Pending 20-Nov-2017 000000000
ES-2604931-T3 New morphinans useful as analgesics Active 23-Dec-2010 0000000000
AU-2011348043-A1 Novel morphinans useful as analgesics Granted 23-Dec-2010 0000000000
US-8987293-B2 Morphinans useful as analgesics Active 23-Dec-2010 0000000000
CA-2822453-C Novel morphinans useful as analgesics Active 23-Dec-2010 C07D221/28
To view Phoenix Pharmalabs’s complete patent history, request access »

Phoenix Pharmalabs Executive Team (5)

Name Title Board Seat Contact Info
William Crossman Chief Executive Officer, President & Board Member
John Lawson Ph.D Co-Founder, Chairman & Chief Scientific Officer
Lawrence Toll Ph.D Co-Founder, Board Member & Chief Neuropharmacologist
Chris Tew Board Member & Executive Vice President, Sales & Marketing and Business Development
Timmy Chou Chief Financial Officer, Senior Vice President & Board Member
To view Phoenix Pharmalabs’s complete executive team members history, request access »

Phoenix Pharmalabs Board Members (5)

Name Representing Role Since
Chris Tew Phoenix Pharmalabs Board Member & Executive Vice President, Sales & Marketing and Business Development 000 0000
John Lawson Ph.D Phoenix Pharmalabs Co-Founder, Chairman & Chief Scientific Officer 000 0000
Lawrence Toll Ph.D Phoenix Pharmalabs Co-Founder, Board Member & Chief Neuropharmacologist 000 0000
Timmy Chou Self Chief Financial Officer, Senior Vice President & Board Member 000 0000
William Crossman Phoenix Pharmalabs Chief Executive Officer, President & Board Member 000 0000
To view Phoenix Pharmalabs’s complete board members history, request access »

Phoenix Pharmalabs Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phoenix Pharmalabs Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
Daniel Levy Angel (individual) Minority 000 0000 000000 0
Deepa Deshpande Angel (individual) Minority 000 0000 000000 0
Jim Myers Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »